SNPX (Synaptogenix, Inc) Yalpi foyda bo'yicha sotuv rentabelligi

Neurotrope (SNPX) kompaniyasining rasmiy ramzlari

Synaptogenix, Inc. (SNPX) uzoq muddatli patent himoyasiga tayangan holda, Altsgeymer kasalligiga qarshi dori vositalarini ishlab chiqadi. GURU.Markets tizimida yalpi foyda foizlari grafigi mavjud bo'lib, u yerda 0.00 joriy metrika qiymatini tashkil etadi. Demensiya terapiyasiga bo'lgan talab iqtisodiy sharoitlardan qat'i nazar barqaror qolmoqda, garchi sinov xarajatlari kapitalizatsiyaga ta'sir ko'rsatayotgan bo'lsa-da. Kompaniyaga tegishli operatsiyalar biomateriallarni utilizatsiya qilish bo'yicha FDA tartibga soluvchi qoidalari bilan qat'iy cheklangan.

SNPX - synaptogen.com Yalpi foyda bo'yicha rentabellik 04.07.2022 - 02.05.2026 oraligʻida

Synaptogenix (SNPX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Fundamental baholash:SNPX, Neurotrope
synaptogen.com seriyali mahsuloti

Portfelni boshqarish nuqtai nazaridan, ushbu ko'rsatkich operatsion samaradorlik filtri vazifasini o'taydi. U daromad va bevosita xarajatlar orasidagi farq sifatida hisoblanadi hamda ma'muriy xarajatlar va investitsiyalarni qoplash uchun mavjud bo'lgan foyda marjasini ko'rsatadi. Synaptogenix, Inc. (SNPX) kompaniyasining yalpi foyda marjasi tuzilmasini tahlil qilish Altsgeymer kasalligi dori vositalari uchun ma'lumotlarni qayta ishlashni avtomatlashtiruvchi AI robotlarini joriy etishning iqtisodiy ta'sirini baholash imkonini beradi.

Muhim raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi foyda bo'yicha rentabellik BrainStorm Cell Therapeutics Inc. (BCLI)|Yalpi rentabellik Cara Therapeutics, Inc (CARA)|Yalpi rentabellik CHRO (Chromocell Therapeutics Corp.)|Yalpi marja ELYM (eliemtx.com)|intracellulartherapies.com - Yalpi rentabellik|LBPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Yalpi marja|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)